Newsletter | October 1, 2025

10.01.25 -- How Can Nanotechnology Transform Drug Delivery?

Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery

Nanoforming techniques are helping develop new patient-centric delivery routes that can improve patient comfort, compliance, and reduce healthcare costs. Learn more in two real-world case study examples.

 

The Flux Performance Of Nanoformed And Untreated PRX Solid Suspensions

Review the application of in vitro flux assays to nanoparticles, with data on how the permeability apparatus can be utilized to characterize the membrane flux performance of an API formulated as a nanosuspension.

 

Expanding Opportunities For Inhaled Drug Delivery

Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.

 

Enabling Subcutaneous Delivery For Improved Patient Compliance

The ability to administer high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens.

 

SOLUTIONS

Best-In-Class Nanodevelopment Capabilities

A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.

• Request Information

 

 

CPHI, Frankfurt | Oct 28, 2025 - Oct 30, 2025

Please visit us at CPHI Frankfurt Booth 6.0A2 to discuss how we can NanoImprove your molecule!

 

Schedule a Meeting